Bendectin and Birth Defects
by Green, Michael D.Edition: Reprint
Format: Paperback
Pub. Date: 1998-02-01
Publisher(s): Univ of Pennsylvania Pr
Other versions by this Author
List Price: $34.95
Buy New
Usually Ships in 2-3 Business Days.
$34.92
Rent Textbook
Select for Price
Rent Digital
$47.94*
Used Textbook
We're Sorry
Sold Out
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation, comparing individual and collective forms of litigation, and illustrating the misunderstandings between scientists and lawyers about the role of science in providing evidence for the legal system.
Table of Contents
| Preface | |
| Acknowledgments | |
| A Birth Defect Child Is Born | |
| Locating Bendectin within the Mass Toxic Landscape | |
| The Science of Determining Toxic Causation | |
| The Food and Drug Administration | |
| The Wm. S. Merrell Company | |
| A Mother's Quest | |
| The Mekdeci Case | |
| The Unraveling of Mekdeci | |
| The Proliferation of Bendectin Litigation | |
| Litigating a Multidistrict Case | |
| The Withdrawal of Bendectin | |
| Forging a Mass Toxic Substances Trial | |
| The Settlement and Unsettlement of MDL-486 | |
| The MDL-486 Trial | |
| Aggregative Procedure in Mass Toxic Substances Litigation | |
| The Third Phase of Bendectin Litigation: Oxendine, Richardson, and the Individual Trials | |
| The Legacy of Bendectin for Toxic Causation Law | |
| The Lessons and Non-Lessons of Bendectin Litigation | |
| Selected Bibliography | |
| Index | |
| Table of Contents provided by Publisher. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.